Senores Pharma unit to buy 14 drugs from Dr. Reddy's

Gujarat's Senores Pharma, via its US arm, is acquiring 14 ANDAs from Dr. Reddy's Labs, comprising 13 approved and one pending drug. This deal, valued at a $421 million market opportunity in the US, uses IPO funds. The acquisition aims to boost Senores' footprint in the US generics market.